Patent · US Active

Methods and systems for antigen screening

US11002731B2 · kind B2 · utility

5Cited by
118References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2019
Grant dateMay 11, 2021
Priority date
Expiry dateApr 4, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC40B70/00
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present disclosure provides compositions, methods, systems, and devices for polynucleotide processing and antigen screening. Polynucleotide processing may be useful for a variety of applications. Antigen screening may comprise the use of one or more engineered cells. Engineered cells may be useful for characterizing one or more analytes including, for example, a polypeptide antigen.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.